Clinuvel Pharmaceuticals Statistics
Total Valuation
CLVLY has a market cap or net worth of 360.77 million. The enterprise value is 234.57 million.
| Market Cap | 360.77M |
| Enterprise Value | 234.57M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | Sep 9, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.63% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 41.32M |
Valuation Ratios
The trailing PE ratio is 15.03.
| PE Ratio | 15.03 |
| Forward PE | n/a |
| PS Ratio | 6.40 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.69 |
| P/FCF Ratio | 24.81 |
| P/OCF Ratio | 24.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.05, with an EV/FCF ratio of 16.13.
| EV / Earnings | 9.78 |
| EV / Sales | 4.03 |
| EV / EBITDA | 7.05 |
| EV / EBIT | 7.21 |
| EV / FCF | 16.13 |
Financial Position
The company has a current ratio of 17.37, with a Debt / Equity ratio of 0.00.
| Current Ratio | 17.37 |
| Quick Ratio | 16.37 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.03 |
| Interest Coverage | 11.55 |
Financial Efficiency
Return on equity (ROE) is 19.59% and return on invested capital (ROIC) is 16.01%.
| Return on Equity (ROE) | 19.59% |
| Return on Assets (ROA) | 14.22% |
| Return on Invested Capital (ROIC) | 16.01% |
| Return on Capital Employed (ROCE) | 22.83% |
| Revenue Per Employee | 3.52M |
| Profits Per Employee | 1.50M |
| Employee Count | 16 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.40% in the last 52 weeks. The beta is 0.88, so CLVLY's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -27.40% |
| 50-Day Moving Average | 7.21 |
| 200-Day Moving Average | 8.45 |
| Relative Strength Index (RSI) | 53.23 |
| Average Volume (20 Days) | 2,109 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CLVLY had revenue of 56.33 million and earned 24.00 million in profits. Earnings per share was 0.48.
| Revenue | 56.33M |
| Gross Profit | 51.16M |
| Operating Income | 31.53M |
| Pretax Income | 35.77M |
| Net Income | 24.00M |
| EBITDA | 32.01M |
| EBIT | 31.53M |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has 122.67 million in cash and 442,711 in debt, giving a net cash position of 122.23 million.
| Cash & Cash Equivalents | 122.67M |
| Total Debt | 442,711 |
| Net Cash | 122.23M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 134.48M |
| Book Value Per Share | 2.69 |
| Working Capital | 132.72M |
Cash Flow
In the last 12 months, operating cash flow was 14.74 million and capital expenditures -205,784, giving a free cash flow of 14.54 million.
| Operating Cash Flow | 14.74M |
| Capital Expenditures | -205,784 |
| Free Cash Flow | 14.54M |
| FCF Per Share | n/a |
Margins
Gross margin is 90.83%, with operating and profit margins of 55.97% and 42.60%.
| Gross Margin | 90.83% |
| Operating Margin | 55.97% |
| Pretax Margin | 63.51% |
| Profit Margin | 42.60% |
| EBITDA Margin | 56.83% |
| EBIT Margin | 55.97% |
| FCF Margin | 25.81% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.42%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 0.42% |
| Dividend Growth (YoY) | 4.80% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 6.46% |
| Buyback Yield | 2.63% |
| Shareholder Yield | 3.05% |
| Earnings Yield | 6.65% |
| FCF Yield | 4.03% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CLVLY has an Altman Z-Score of 25.58.
| Altman Z-Score | 25.58 |
| Piotroski F-Score | n/a |